Arda Biomaterials
$5.2M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Arda Biomaterials is currently valued at $14.7M as of March 19, 2025. The company has raised a total of $6.7M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.20x, Arda Biomaterials has achieved a valuation that is 2.20 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
Arda Biomaterials's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Arda Biomaterials Worth in 2025?
As of 2025, Arda Biomaterials is valued at $14.7M, based on the company's Seed Round funding round in March 19, 2025. This valuation positions Arda Biomaterials as one of the leading private companies in the sector.
Arda Biomaterials Valuation History
Arda Biomaterials's funding history demonstrates steady growth and investor confidence.
How Arda Biomaterials Valuation is Determined
Private company valuations like Arda Biomaterials's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Arda Biomaterials Valuation FAQs
Is Arda Biomaterials profitable?
Arda Biomaterials has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Arda Biomaterials's valuation compare to competitors?
Arda Biomaterials is valued at $14.7M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Arda Biomaterials IPO?
Arda Biomaterials has not announced plans for an initial public offering. Until an IPO, investors can access Arda Biomaterials shares through secondary market platforms.